Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mutation testing in Charcot-Marie-Tooth neuropathy.

G A Nicholson1

  • 1University of Sydney, Molecular Genetics Laboratory, Concord Hospital, NSW, Australia. molmed@medicine.su.oz.au

Annals of the New York Academy of Sciences
|December 10, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The genotype-phenotype landscape of familial amyotrophic lateral sclerosis in Australia.

Clinical genetics·2017
Same author

Quantitative muscle ultrasound as a biomarker in Charcot-Marie-Tooth neuropathy.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2016
Same author

Mutation analysis of genes within the dynactin complex in a cohort of hereditary peripheral neuropathies.

Clinical genetics·2015
Same author

Transanal rectal resection: an initial experience of 20 cases.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2015
Same author

Laparoscopic rectopexy is feasible and safe in the emergency admission setting.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2015
Same author

Augmenting the decision making process in acute appendicitis: A retrospective cohort study.

International journal of surgery (London, England)·2015

Targeted genetic testing is more effective for diagnosing Charcot-Marie-Tooth (CMT) neuropathy subtypes. Analyzing specific mutations like connexin32, PMP22, and P0 based on inheritance patterns and severity improves diagnostic yield.

Area of Science:

  • Neurology
  • Genetics
  • Molecular Biology

Background:

  • Charcot-Marie-Tooth (CMT) neuropathy is a heterogeneous group of inherited peripheral nervous system disorders.
  • Accurate genetic diagnosis is crucial for understanding disease mechanisms and patient management.
  • Current diagnostic approaches involve testing for various gene mutations associated with CMT.

Purpose of the Study:

  • To evaluate the optimal strategy for mutation testing in Charcot-Marie-Tooth (CMT) neuropathy.
  • To determine the diagnostic yield of testing for specific mutations (CMT1A duplication, connexin32, PMP22, P0) in CMT patients.

Main Methods:

  • Consecutive CMT patients with available family history and median motor conduction velocities < 50 m/sec were included.
  • Testing involved CMT1A duplication and point mutations in connexin32, peripheral myelin protein 22 (PMP22), and myelin protein zero (P0).

Related Experiment Videos

  • Patient selection criteria were based on inheritance patterns (e.g., no male-to-male transmission for CMTX) and clinical severity (e.g., Dejerine-Sottas cases).

    • Main Results:

    • Connexin32 mutations were primarily identified in families with no male-to-male CMT inheritance and CMTX neurophysiological indicators.
    • PMP22 and P0 mutations were found in Dejerine-Sottas cases or severe dominant CMT1.
    • Blind testing of CMT1 families for these mutations yielded limited diagnostic value.

    Conclusions:

    • Selective genetic testing strategies are more efficient for diagnosing CMT subtypes.
    • Mutation analysis should be guided by clinical presentation, family history, and neurophysiological findings.
    • Broad, unselected genetic screening for CMT1-associated genes is not cost-effective.